novartis glp 1 drug GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients Details of failed studies cast
Description
Patients can still get coverage if they have a diagnosis of Type 2 diabetes, cardiovascular disease or sleep apnea, but not if they have obesity only or for weight loss generally
Although not originally developed for weight loss, many patients lose significant weightsome up to 25 pounds
[DOI] [PubMed] [Google Scholar] 34.Garca-Prez L.E., Alvarez M., Dilla T., Gil-Guilln V., Orozco-Beltrn D
Neurobiol Aging (2018) 62:3444
